期刊文献+

苦酸通调方对自发性糖尿病大鼠腹部脂肪组织中FAS蛋白表达的影响

下载PDF
导出
摘要 目的:观察苦酸通调方对自发性糖尿病大鼠腹部脂肪中脂肪酸生成酶(FAS)蛋白表达的影响。方法:将高脂饲料喂养的雄性SPF级ZDF(Zucker Diabetic Fatty)大鼠随机分为模型组、苦酸通调组、吡格列酮组,普通饲料喂养的雄性SPF级ZL(Zucker Lean)大鼠为正常对照组,每组各10只。苦酸通调组按照3.29g·kg-1灌胃给药,吡格列酮组按照1.07mg·kg-1灌胃给药,模型组、正常对照组予等体积蒸馏水灌胃,连续12周。经Western blot法检测各组大鼠腹部脂肪组织中FAS蛋白的表达情况。结果:与正常组比较,模型组FAS蛋白表达明显升高(P<0.05);苦酸通调方组及吡格列酮组可明显降低FAS蛋白表达,与模型组比较有明显改善(P<0.01)。结论:苦酸通调方可明显降低糖尿病大鼠腹部脂肪组织中FAS蛋白的表达。
出处 《中医药通报》 2016年第2期53-55,共3页 Traditional Chinese Medicine Journal
基金 吉林省自然科学基金项目(No.201115169)
  • 相关文献

参考文献9

  • 1陈艳芬,王春怡,李卫民,高英,唐春萍,杨超燕,薛秀敏.黄芪葛根汤对糖尿病心肌病大鼠氧化应激和NF-κB表达的影响[J].中成药,2012,34(8):1428-1432. 被引量:30
  • 2Lanuza - Masdeu J, Ar6valo mI, Vila C, et al. In vivo JNK activation in pancreatic β- cells leads to glucose intolerance caused by insulin resistance in pancreas [ J ]. Diabetes,2013,62 (7) :2308 - 2317.
  • 3Menendez J A. Vazquez Martin A, Ortega F J, Fernandez Real JM. Fatty acid synthase. Association with insulin resistance, type 2 diabetes and cancer [ J]. Clin Chem,2009,55 (3) :425 - 38.
  • 4ChoiW J,Jeon B N,Park H,et al. Proto oncogene FBI- 1 (Pokemon) and SREBP - 1 synergistically activate transcription of fattyacid synthase gene(FASN) [J]. Chin Phamaeol Bu11,2006,22(7) :780 -784.
  • 5Pick A, Clark J, Kubstrup C, et al. Role of apoptosis in failure of beta - cell mass compensation for insulin resistance and beta - cell defects in the male Zucker diabetic fatty rat [ J]. Diabetes, 1998,47 (3) :358 - 64.
  • 6朴春丽,陈曦,于敏,韩笑,何泽,包扬.消渴脂平干预自发Ⅱ型糖尿病大鼠炎症及脂代谢的实验研究[J].吉林中医药,2011,31(4):379-380. 被引量:4
  • 7王淑俊,朴春丽,刘禹辛.苦酸通调1号方治疗肥胖型2型糖尿病40例临床观察[J].中华实用中西医杂志,2009,22(4):221-222.
  • 8朴春丽,邓悦,米佳.苦酸通调法抑制糖尿病脂肪组织炎症机制的理论探讨[J].中华实用中西医杂志,2009,22(3):146-148.
  • 9朴春丽,陈曦,米佳.苦酸通调法治疗糖尿病前期的临床研究[J].中外健康文摘,2012,9(44):128.

二级参考文献15

  • 1张红敏,谢春光,陈世伟.动脉粥样硬化、2型糖尿病等疾病发病学说中低度炎症的中医病理探讨[J].中医杂志,2005,46(2):83-85. 被引量:57
  • 2王丽英,张红敏,谢春光,陈世伟.中医释义动脉粥样硬化及2型糖尿病低度炎症的发生条件[J].时珍国医国药,2005,16(7):662-663. 被引量:52
  • 3Hotamisligil GS.Inflammation and metabolic disorders[J].Nature,2006,444(7121):860-867.
  • 4McGarry JD.Dysregulation of fatty acid metabolism in the etiology of type 2 diabetes[J].Diabetes,2002,51 (1):7-18.
  • 5Kutlu B,Darville MI,Cardozo AK,et al.Molecular regulation of monocyte chemoattractant protein-1 expression in pancreatic betacells[J].Diabetes,2003,52(2):348-355.
  • 6Kiss L, Szab6 C. The pathogenesis of diabetic complications: the role of DNA injury and poly ( ADP-ribose ) polymerase activation in peroxynitrite-mediated cytotoxicity [ J ]. Mem lnst Oswaldo Cruz, 2005, 100(Suppl 1) : 29-37.
  • 7Asghar O, A1-Sunni A, Khavandi K, et al. Diabetic cardiomyop- athy[J]. Clin Sci (Lond), 2009, 116(10) : 741-760.
  • 8Stratmann B, Stork I, Tschoepe D. Diabetic cardiomyopathy-a type of coronary artery disease [ J ]. Internist ( Berl), 2008, 49 (4) : 436-440.
  • 9Karnik A A, Fields A V, Shannon R P. Diabetic cardiomyopathy [J]. Curt Hypertens Rep, 2007, 9(6): 467-473.
  • 10Okoshi K, Guinaaraes J F, Di Muzio B P, et al. Diabetic cardio- myopathy[ J]. Arq Bras Endocrinol Metabol, 2007,51 (2) : 160- 167.

共引文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部